HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Speaker at Pharmaceutical Conference - Thomas J. Webster
Keynote Presentation (In-Person)
Thomas J. Webster, Mansfield Bioincubator, United States

Today’s biomaterials are harming the environment and left unchanged, are predicted to continue to harm the environment in the decades ahead at an alarming rate. Whether through a large carbon footprint during manufacturing, catheter waste, or extensive polymeric cell cultur [....] » Read More

Speaker at Drug Delivery Events - Miroslav Radenkovic
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Hypertension is a common condition characterized by persistently high blood pressure (140/90 mmHg or higher). Lowering high blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Regardless of outstanding result [....] » Read More

Speaker at Pharma conferences - Priya Hays
Oral Presentation (In-Person)
Priya Hays, Hays Documentation Specialists, LLC, United States

Background: PARP inhibitors and CDK 4/6 inhibitors have been studied extensively as model targeted agents for advanced and metastatic breast cancer with hormone receptor positive/HER2 negative molecular subtype, the most common in the patient population. Both agents have been eva [....] » Read More

Speaker at Pharma Conferences - Gurpreet Singh
Oral Presentation (In-Person)
Gurpreet Singh, IQVIA, United Kingdom

The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical Companies based on projected R&D spending in 2026 are Roche, Johnson & Johnson, Merck [....] » Read More

Speaker at Pharmaceutical Conference - Thomas Ullrich
Oral Presentation (In-Person)
Thomas Ullrich, Novartis Biomedical Research, Switzerland

Long-acting injectable (LAI) medications represent the combination of a powerful drug substance and an injectable drug formulation that guarantees that the affected tissue is consistently exposed to the active molecule for an extended therapeutic treatment period without elicitin [....] » Read More

Speaker at Pharma Conferences - Yusuke Shimoyama
Oral Presentation (In-Person)
Yusuke Shimoyama, Tokyo Institute of Technology, Japan

Pharmaceutical formulation techniques have been developed as achieving controlled-release system and high bioavailability of active pharmaceutical ingredients (APIs). Formation of the pharmaceutical suspension with nanoparticles or liposomes is one of the dosage forms to increase [....] » Read More

Speaker at Pharma conferences - Anush
Oral Presentation (In-Person)
Anush, National Academy of Sciences of the Republic of Armenia, Armenia

Furo(thieno)[2,3-b]pyridines are “privileged medicinal scaffolds”, used for the development of pharmaceutical agents, showing a wide range of pharmacological activities. Their annulated derivatives attracted big interest of the scientific community due to their broad [....] » Read More

Speaker at Drug Delivery Events - Shereen M. Assaf
Oral Presentation (In-Person)
Shereen M. Assaf, Jordan University of Science and Technology, Jordan

Benign prostatic hyperplasia (BPH), an enlargement of the prostate affecting older men, leads to urinary complications. Oral administration of Dutasteride (DTS) is a common treatment, but it poses challenges for the elderly, including difficulty in taking the medication by mouth, [....] » Read More

Speaker at Drug Delivery Events - Shereen M. Assaf
Oral Presentation (In-Person)
Shereen M. Assaf, Jordan University of Science and Technology, Jordan

Levodopa, an essential precursor of dopamine, was widely used to address motor disorders in the early stages of Parkinson's disease. However, its effectiveness was hindered by a short plasma half-life, enzymatic conversion in the systemic circulation, limited absorption in th [....] » Read More

Speaker at Pharmaceutical Conference - Deisy Yurley Rodriguez Sarmiento
Oral Presentation (In-Person)
Deisy Yurley Rodriguez Sarmiento, Universidad Autonoma de Bucaramanga, Colombia

This presentation will show into the intricate cellular signaling mechanisms mediated by kisspeptin-10 (KP10) in cervical cancer cells, focusing specifically on its interaction with the Kiss1R receptor. The role of KP10 in modulating various G protein-coupled receptor (GPCR) path [....] » Read More

Speaker at Pharma conferences - Rehan Haider
Oral Presentation (In-Person)
Rehan Haider, Riggs Pharmaceuticals, Pakistan

Understanding medical education involves a comprehensive grasp of the multifaceted processes that prepare individuals for medical practice. It encompasses various domains, including curriculum design, teaching methodologies, assessment strategies, and the broader socio-cultural c [....] » Read More

Speaker at Pharma Conferences - Ghazala Rubi
Oral Presentation (In-Person)
Ghazala Rubi, Lahore General Hospital, Pakistan

Background: Coronavirus disease-2019 (Covid-19) caused by novel Corona Virus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), spreads primarily through close contact with respiratory droplets. This novel coronavirus has also been linked to ocular manifest [....] » Read More

Speaker at Drug Delivery Events - Djimeli Namekong Merline
Oral Presentation (In-Person)
Djimeli Namekong Merline, Dschang University, Cameroon

Bacteria are responsible for a large number of diseases worrying the world today. Medicinal plants have always been used by poor communities of the African continent as an alternative for the treatment of those diseases. Typhoid fever is one of those diseases caused by salmonella [....] » Read More

Speaker at Pharma Conferences - Suren Azad Ramadhan
Oral Presentation (In-Person)
Suren Azad Ramadhan, Knowledge University, Iraq

Objective: The major goal of this current experimental study was to use various hydrotropic agents in the formation of solid dispersion-based hydrotropic blends to improve the solubility properties of poor aqueous soluble drug atorvastatin calcium (ATV). Since, atorvastatin calci [....] » Read More

Speaker at Pharma Conferences - Sarhang Hayyas Mohammed
Oral Presentation (In-Person)
Sarhang Hayyas Mohammed, Knowledge University, Iraq

Background and Objective: Sulfonamides are a type of antibiotic that are used to treat several infections caused by microorganisms. Sulfonamides are bacteriostatic, meaning they prevent bacterial growth. This study aimed to produce compounds with better antimicrobial activity. M [....] » Read More

Speaker at Pharmaceutical Conference - Fatma Haddad
Poster Presentation (In-Person)
Fatma Haddad, University of Bradford, United Kingdom

Luteolin is a natural flavonoid abundant in several fruits, vegetables, and medicinal herbs. Although luteolin has numerous pharmacological activities, its low water solubility and bioavailability restrict its therapeutic efficacy. This work aims to overcome these limitations by [....] » Read More

Speaker at Drug Delivery Events - Saleem iqbal
Poster Presentation (In-Person)
Saleem iqbal, CHU Research Center and Laval University, Canada

SARS-CoV-2 exploits the homotrimer transmembrane Spike glycoproteins (S protein) during host cell invasion. Omicron, delta, and prototype SARS-CoV-2 receptor-binding domain show similar binding strength to hACE2 (Angiotensin-Converting Enzyme 2). Here we utilized multi-ligand vir [....] » Read More

Speaker at Drug Delivery Events - Andreia Bagliotti Meneguin
Poster Presentation (In-Person)
Andreia Bagliotti Meneguin, Sao Paulo State University, UNESP, Brazil

Ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD) affecting the colon and rectum, has an unknown etiology. Key symptoms include reduced pH, accelerated colonic transit, diarrhea, and imbalance in intestinal microbiota (dysbiosis). Probiotics (PBTs), when survivi [....] » Read More

Speaker at Pharma Conferences - Fernando Rogerio Pavan
Poster Presentation (In-Person)
Fernando Rogerio Pavan, Sao Paulo State University, UNESP, Brazil

Tuberculosis (TB) is an infectious disease that affects millions of people annually and resistance to available antibiotics has worsened this scenario. Another particularity of Mycobacterium tuberculosis, the main etiologic agent of TB, is its ability to survive inside of macroph [....] » Read More

Speaker at Pharma Conferences - Rassa Pegahi
Poster Presentation (In-Person)
Rassa Pegahi, UPSA, France

Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use, debate exists regarding the analgesic mechanism of action (MoA) of paracetamol. A growing body of evidence [....] » Read More

Speaker at Pharma conferences - Yuna Tatsumi
Poster Presentation (In-Person)
Yuna Tatsumi, Tokyo Institute of Technology, Japan

Pharmaceutical cocrystal is one of the crystal engineering techniques to improve the solubility and bioavailability of active pharmaceutical ingredients (APIs). Cocrystal is a crystal composed of API and other molecules called as coformer. There are many fabrication techniques fo [....] » Read More

Speaker at Pharma Conferences - Pyung Bok Lee
Poster Presentation (In-Person)
Pyung Bok Lee, Seoul National University, Korea, Republic of

Background: Transforaminal Epidural Steroid injection(TFESI) is known to be an effective treatment for pain caused by lumbar diseases such as intervertebral disc herniation , spinal stenosis. This study aims to find out the optimal angle of needle insertion at the time of re [....] » Read More

Speaker at Pharma conferences - Ahmad Abdullah Salawi
Poster Presentation (In-Person)
Ahmad Abdullah Salawi, Jazan University, Saudi Arabia

The current project was designed to prepare an oil-in-water (oil/water) hypericin nanoemulsion using eucalyptus oil for the preparation of an oil phase with chitosan as an emulsion stabilizer. The study might be a novelty in the field of pharmaceutical sciences, especially in the [....] » Read More

Speaker at Pharma Conferences - Stella Kafkala
Poster Presentation (In-Person)
Stella Kafkala, Genepharm Pharmaceutical Company, Greece

Eltrombopag olamine is the active substance of the innovator product Revolade, which is indicated for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) and acquired severe aplastic anemia (SAA). The molecule of eltrombopag acquires 6 protonatable site [....] » Read More

Speaker at Pharma Conferences - Ameera Bataineh
Poster Presentation (In-Person)
Ameera Bataineh, Jordan University of Science and Technology, Jordan

Cystic fibrosis disease is a genetic respiratory disease associated with severe respiratory complications with problematic drug delivery. Pseudomonas aeruginosa pulmonary infections is considered a leading cause of pulmonary morbidity in adult patients with cystic fibrosis. Levof [....] » Read More

Speaker at Pharmaceutical Conference - Mutaz S. Salem
Poster Presentation (In-Person)
Mutaz S. Salem, Jordan University of Science and Technology, Jordan

Conventional oral formulations are mainly absorbed in the small intestine. This limits their use in the treatment of some diseases associated with the colon, where the drug has to act topically at the inflammation site. This paved the way for the development of a smart colonic dr [....] » Read More

Speaker at Pharma Conferences - Seifu Hailu Ambissa
Poster Presentation (In-Person)
Seifu Hailu Ambissa, Yanet Health and Business College, Ethiopia

This study investigated prevalence and determinants of self-medication practice, with the intention to develop a strategy to reduce irresponsible self-medication practice among rural households in Gimbichu district, Ethiopia. The study was quantitative, descriptive cross-sectiona [....] » Read More

Speaker at Pharma Conferences - Christina Haile Shoddo
Poster Presentation (In-Person)
Christina Haile Shoddo, Armauer Hansen Research Institute, Ethiopia

Complex coacervation is one of the microencapsulation techniques by which encapsulated substances release profile improved. This study was conducted by using complex coacervation to formulate and optimize microcapsules of the Cymbopogan martini essential oil.  Preliminary st [....] » Read More

Speaker at Drug Delivery Events - Sergey Suchkov
Keynote Presentation (In-Person)
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

Traditionally a disease has been defined by its clinical presentation and observable characteristics, not by the underlying molecular mechanisms, pathways and systems biology-related processes specific to a particular patient (ignoring persons-at-risk). A new systems approach to [....] » Read More

Speaker at Pharma Conferences - Luis Jesus Villarreal Gomez
Keynote Presentation (In-Person)
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico

Wound dressings play a pivotal role in wound care by cleansing, shielding, and covering wounds, thereby influencing healing duration, cost-effectiveness, and patient comfort. Electrospun fibers emerge as a promising avenue in this field due to their diverse attributes, including [....] » Read More

Speaker at Drug Delivery Events -  Andreas M Papas
Keynote Presentation (In-Person)
Andreas M Papas, Antares Health Products, United States

Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glyco [....] » Read More

Speaker at Pharmaceutical Conference - Shripriya Kalbhavi
Oral Presentation (Virtual)
Shripriya Kalbhavi, Lynbrook High School, United States

Despite the widespread use of hypodermic needles in intradermal medication delivery, they remain a source of pain and trauma in patients young and old. The research introduces a novel approach to active medication delivery using microneedle arrays, utilizing the high swellability [....] » Read More

Speaker at Pharma Conferences - Elisabetta Stretti
Oral Presentation (Virtual)
Elisabetta Stretti, University of Patras, Greece

Drug-coated balloon (DCB) treatment has recently emerged as an effective non-stent-based strategy for the treatment of atherosclerotic arteries in peripheral artery disease (PAD). DCBs are designed to dilate into the stenotic lesions while delivering antiproliferative drugs to lo [....] » Read More

Speaker at Drug Delivery Events - Raja Chakraverty
Oral Presentation (Virtual)
Raja Chakraverty, Indian Council of Medical Research, India

The study was conducted to gather information to assess the extent of impact of antimicrobial stewardship (AMSP) practices on antimicrobial prescribing patterns and bacterial resistance profiles among indoor patients across ten ICU and non-ICU departments at the Institute of Post [....] » Read More

Speaker at Drug Delivery Events - Pratip kashinath chaskar
Oral Presentation (Virtual)
Pratip kashinath chaskar, D Y Patil University School of Pharmacy Navi Mumbai, India

The forthcoming presentation will delve into the fundamental tenets of Green Chemistry, highlighting key methodologies such as Phase Transfer Catalysis (PTC), Ionic Liquids (IL), Sonochemistry, and Microwave Irradiation (MWI). These cutting-edge approaches epitomize the evolution [....] » Read More

Speaker at Drug Delivery Events - Ashwin
Oral Presentation (Virtual)
Ashwin, Dr. Vishwanath Karad MIT World Peace University, India

In response to the escalating demand for personalized medicine tailored to individual genetic variations, a critical need has arisen, particularly in the realm of diseases characterized by genetic diversity, such as cancer. Concurrently, the complexity of managing diseases that n [....] » Read More

Speaker at Pharmaceutical Conference - Ganesh Kumar S
Oral Presentation (Virtual)
Ganesh Kumar S, St. Peter’s Institute of Higher Education and Research, India

The emergence of antibiotic resistance in retort to environmental pollutants during wastewater treatment still remains elusive. Here, we first to investigate the emergence of antibiotic resistance in an environmental non-pathogenic bacterium, Pseudoxanthomonas mexicana isolated f [....] » Read More

Speaker at Pharma Conferences - Mangesh Dagawal
Oral Presentation (Virtual)
Mangesh Dagawal, Smt. Radhabai Sarda Arts, Commerce and Science College, India

HPTLC based methods are being explored as an important tool in routine drug analysis. HPTLC screening reveals the species' relatedness and uniqueness. HPTLC fingerprint of a plant species provide information for identification, standardization and quality control of the medic [....] » Read More

Speaker at Pharma Conferences - Deepika Sharma
Oral Presentation (Virtual)
Deepika Sharma, CGC Mohali Punjab, India

Among the fungal genera, members of the genus Candida are most common causal organisms of human infections. In recent years, increasing drug resistance in fungal pathogenic strains specifically, clinical strains require immediate attention to develop alternative antifungal agents [....] » Read More

Speaker at Drug Delivery Events - Dinesh Kumar
Oral Presentation (Virtual)
Dinesh Kumar, Desh Bhagat University, India

Introduction: Carvedilol is poorly water-soluble and show low oral bioavailability. Solubility enhanced of low water soluble drug enhanced by solid dispersion method.  Method: Design expert-13 software used to enhance the solubility of poorly water soluble drug by solid dis [....] » Read More

Speaker at Pharmaceutical Conference - Asish Bhaumik
Oral Presentation (Virtual)
Asish Bhaumik, School of Pharmaceutical Science, India

Introdution: 1, 3, 4-oxadiazole is a five membered heterocyclic aromatic compound containing two nitrogen atom at position three and four and one oxygen atom present at position one. 1, 3, 4 oxadiazole is thermally stable than other oxadiazoles, these oxadiazole are very&nbs [....] » Read More

Speaker at Pharma Conferences -  Anu Geetam P K M
Oral Presentation (Virtual)
Anu Geetam P K M, D G Govt Arts College For Women, India

Seaweeds are ocean plants which are classified by botanist as microphysis marine algae(Marine algae).They are microscopic, Multicellular and photosynthetic eukaryotic organisms. They were seen in different shapes, colours and size all over the earth. Seaweed refers to three taxon [....] » Read More

Speaker at Drug Delivery Events - Tejaswi
Oral Presentation (Virtual)
Tejaswi, Nalanda institute of pharmaceutical sciences, India

The era of ‘one-size-fits-all’ treatment approaches is becoming history for pharmaceutical manufacturing with the future encountering a revolution in drug development through the introduction of additive manufacturing technologies. The innovative elements of this disr [....] » Read More

Speaker at Pharmaceutical Conference - Sumaira Kanwal
Oral Presentation (Virtual)
Sumaira Kanwal, COMSATS University Islamabad, Sahiwal Campus, Pakistan

Drug delivery systems refer to technologies and approaches used to deliver pharmaceutical compounds to specific targeted sites within the body. The goal of drug delivery is to improve the therapeutic efficacy of medications while minimizing side effects and enhancing patient comp [....] » Read More

Speaker at Pharma conferences - Afonin S.M
Poster Presentation (Virtual)
Afonin S.M, National Research University of Electronic Technology, Russian Federation

An electro magneto elastic actuator is electro magneto mechanical device intended for actuation of mechanisms, systems based on the piezoelectric, electrostriction, piezomagnetic, magnetostriction effects, converts electric or magnetic signals into mechanical movement and force. [....] » Read More

Speaker at Pharmaceutical Conference - Hasmik Zanginyan
Poster Presentation (Virtual)
Hasmik Zanginyan, Institute of Molecular biology, Armenia

The most common disease of the entire group of myelin diseases is multiple sclerosis (MS). Experimental autoimmune encephalomyelitis (EAE) in rats is an experimental model of human multiple sclerosis. Usually the disease begins at a young age and almost inevitably leads to disabi [....] » Read More